EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Association between statin usage and mortality outcomes in aging U.S. cancer survivors: a nationwide cohort study

Shan Ding, Fengling Yang, Pan Lai, Weiwen Jiang, Minze Chen, Yijun Ge, Liting Zhou, Shaozhuang Chen, Jiaqi Zhang, Yanrong Ye

Aging Clinical and Experimental Research · 2024

DOI: 10.1007/s40520-024-02851-2 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Aging Clinical and Experimental Research, 2024. Verfasst von Shan Ding und 9 weiteren Autor:innen. Beteiligte Einrichtung: Zhongshan Hospital (Xiamen), Fudan University, Xiamen, 361015, China. Hauptthemen laut MEDLINE: Hydroxymethylglutaryl-CoA Reductase Inhibitors, Cancer Survivors. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The population of Aging cancer survivors in the United States has surged to over 16.9 million. Research on the relationship between statin usage and post-cancer survival rates remains limited.

Aims

This study aims to investigate the association between statin use and various causes of mortality among aging cancer survivors.

Methods

We analyzed NHANES data from 1999 to 2018, Statin usage, both hydrophilic and lipophilic, was derived from NHANES prescription records. We utilized Cox proportional hazards models to associate statin utilization with mortality, differentiating causes of death according to statin type and patterns of use.

Results

Within a cohort of 2,968 participants, statin usage was categorized into non-users (1,738), hydrophilic statin users (216), and lipophilic statin users (982). Compared to those who did not use statins, individuals prescribed hydrophilic statins did not show a reduced risk of all-cause mortality (adjusted hazard ratio [HR] 1.01; 95% confidence interval [CI] 0.72–1.41; P = 0.960), as outlined in Model 3. In contrast, the group receiving lipophilic statins exhibited a notable decrease in all-cause mortality risk (adjusted HR, 0.77; P = 0.003). Nonetheless, both hydrophilic and lipophilic statins were effective in diminishing the risk associated with cancer from its onset until death, with hydrophilic statins showing a greater level of efficacy.

Discussion

The potential of statins to reduce cancer-related mortality may provide avenues for targeted clinical interventions and management strategies.

Conclusions

Our study reveals that the use of lipophilic statins is significantly associated with lower all-cause and cancer-cause mortality risks among aging cancer survivors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hydroxymethylglutaryl-CoA Reductase InhibitorsCancer SurvivorsHumansFemaleMaleAgedUnited StatesMiddle AgedCohort StudiesNeoplasmsNutrition SurveysAgingProportional Hazards ModelsCause of Death

Stichwörter der Autor:innen

AgingCancer survivorsMortalityNHANESStatins

Substanzen

Hydroxymethylglutaryl-CoA Reductase Inhibitors

Autor:innen und Institutionen

  • Zhongshan Hospital (Xiamen), Fudan University, Xiamen, 361015, China.
  • Longyan First Affiliated Hospital of Fujian Medical University, Longyan, 364000, China. yangfengling0634@163.com.
  • Peking University First Hospital, Beijing, 100034, China.
  • Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
  • Faculty of Health and Environmental Sciences, Auckland University of Technology, Auckland, 0627, New Zealand.
  • Shenzhen Campus of Sun Yat-Sen University, Shenzhen, 518107, China.

Zitieren

APA

Ding, S., Yang, F., Lai, P., Jiang, W., Chen, M., Ge, Y., Zhou, L., Chen, S., Zhang, J., & Ye, Y. (2024). Association between statin usage and mortality outcomes in aging U.S. cancer survivors: a nationwide cohort study. Aging Clinical and Experimental Research. https://doi.org/10.1007/s40520-024-02851-2

Vancouver

Ding S, Yang F, Lai P, Jiang W, Chen M, Ge Y, et al. Association between statin usage and mortality outcomes in aging U.S. cancer survivors: a nationwide cohort study. Aging Clinical and Experimental Research. 2024. doi:10.1007/s40520-024-02851-2

BibTeX
@article{Ding2024,
  author = {Ding, Shan and Yang, Fengling and Lai, Pan and Jiang, Weiwen and Chen, Minze and Ge, Yijun and Zhou, Liting and Chen, Shaozhuang and Zhang, Jiaqi and Ye, Yanrong},
  title = {Association between statin usage and mortality outcomes in aging U.S. cancer survivors: a nationwide cohort study},
  journal = {Aging Clinical and Experimental Research},
  year = {2024},
  doi = {10.1007/s40520-024-02851-2}
}
Kostenlos starten →